Related references
Note: Only part of the references are listed.Changes in conjunctival cytology and tear function tests with radioiodine treatment for hyperthyroidism
Gokhan Koca et al.
ANNALS OF NUCLEAR MEDICINE (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Salivary and Lacrimal Gland Dysfunction After Remnant Ablation with Radioactive Iodine in Patients with Differentiated Thyroid Carcinoma Prepared with Recombinant Human Thyrotropin
Pedro Weslley Rosario et al.
THYROID (2013)
Lacrimal drainage system obstruction associated to radioactive iodine therapy for thyroid carcinoma
Fabricio Lopes da Fonseca et al.
ARQUIVOS BRASILEIROS DE OFTALMOLOGIA (2012)
Sialoadenitis secondary to 131I therapy for well-differentiated thyroid cancer
D. Van Nostrand
ORAL DISEASES (2011)
Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies
Peter C. Austin
PHARMACEUTICAL STATISTICS (2011)
Increasing Incidence of Differentiated Thyroid Cancer in the United States, 1988-2005
Amy Y. Chen et al.
CANCER (2009)
The Benefits and Risks of I-131 Therapy in Patients with Well-Differentiated Thyroid Cancer
Douglas Van Nostrand
THYROID (2009)
Second Primary Malignancy Risk After Radioactive Iodine Treatment for Thyroid Cancer: A Systematic Review and Meta-analysis
Anna M. Sawka et al.
THYROID (2009)
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer
Aaron. P. Brown et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
The carcinogenic effects of radioiodine therapy for thyroid carcinoma
Florent de Vathaire
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2008)
The epidemiology of second primary cancers
Lois B. Travis
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Second primary cancers in thyroid cancer patients:: A multinational record linkage study
TC Sandeep et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Thyroid cancer and multiple primary tumors in the SEER cancer registries
CM Ronckers et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Contemporary management of thyroid cancer
DR Blankenship et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2005)
Risk of second primary cancer following differentiated thyroid cancer
E Berthe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2004)
Second primary malignancies in thyroid cancer patients
C Rubino et al.
BRITISH JOURNAL OF CANCER (2003)
Radioactive iodine and the salivary glands
SJ Mandel et al.
THYROID (2003)
Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment
M Caglar et al.
CLINICAL NUCLEAR MEDICINE (2002)
Long-term impairment of the lacrimal glands after radioiodine therapy: a cross-sectional study
G Zettinig et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2002)
Share Paper
